FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.21 | FHIR Version n/a User: [n/a]

30611000001101: Erythrocin 500 tablets (Abbott Laboratories Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Erythrocin 500 tablets (Abbott Laboratories Ltd)
\UK product\Virtual medicinal product\Product containing precisely erythromycin (as erythromycin stearate) 500 milligram/1 each conventional release oral tablet\Erythrocin 500 tablets (Abbott Laboratories Ltd)
\UK product\Virtual therapeutic moiety\Erythromycin\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin (as erythromycin stearate) 500 milligram/1 each conventional release oral tablet\Erythrocin 500 tablets (Abbott Laboratories Ltd)
\UK product\Trade family\Erythrocin\Erythrocin 500 tablets (Abbott Laboratories Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16990501000001119 Erythrocin 500 tablets (Abbott Laboratories Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

111567301000001112 Erythrocin 500 tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Is a	Product containing precisely erythromycin (as erythromycin stearate) 500 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has excipient	Sorbic acid	false	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has active ingredient	Bactericide	false	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has active ingredient	Erythromycin stearate	false	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has active ingredient	Substance with antibacterial mechanism of action	false	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Is a	Erythrocin	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Erythromycin	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has specific active ingredient	Erythromycin stearate	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd)	Has basis of strength substance	Erythromycin	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet	Is pack of	False	Erythrocin 500 tablets (Abbott Laboratories Ltd)	Inferred relationship	Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet	Has AMP	True	Erythrocin 500 tablets (Abbott Laboratories Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16990501000001119	Erythrocin 500 tablets (Abbott Laboratories Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
111567301000001112	Erythrocin 500 tablets (Advanz Pharma)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module